Basics Akero Therapeutics, Inc. IPO Date: July 17, 2019 Sector: Healthcare Industry: Biotech Market Cap: $4.49B Activated in VL: True Average Daily Range Avg Daily Range: $0.76 | 2.76% Avg Daily Range (30 D): $0.07 | 0.12% Avg Daily Range (90 D): $0.51 | 1.06% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): 1.52M Avg Daily Volume (90 D): 1.71M Trade Size Avg Trade Size (Sh.): 68 Avg Trade Size (Sh.) (30 D): 111 Avg Trade Size (Sh.) (90 D): 93 Institutional Trades Total Inst.Trades: 3,135 Avg Inst. Trade: $2.96M Avg Inst. Trade (30 D): $4.11M Avg Inst. Trade (90 D): $3.85M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.35M Avg Closing Trade (30 D): $6.23M Avg Closing Trade (90 D): $7.78M Avg Closing Volume: 124.71K     News Nov 20, 2025 @ 9:57 PM Halper Sadeh LLC Encourages SEE, AXTA, SEMR, AKRO ... Source: Halper Sadeh Llc Nov 18, 2025 @ 1:30 AM SHAREHOLDER ALERT: The M&A Class Action Firm Conti... Source: Juan Monteverde Nov 7, 2025 @ 6:40 PM Halper Sadeh LLC Encourages JAMF, CADE, AKRO, GES ... Source: Halper Sadeh Llc Nov 6, 2025 @ 10:50 PM BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve... Source: Brodsky & Smith Nov 5, 2025 @ 6:30 AM Novo Nordisk's sales increased by 12% in Danish kr... Source: Novo Nordisk Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3.74 $-.99 $-.86 Diluted EPS $-3.75 $-.99 $-.86 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -292.82M $ -81.57M $ -70.51M Operating Income / Loss $ -330.02M $ -90.24M $ -80.87M Cost of Revenue $ $ $ Net Cash Flow $ -140.03M $ -44.42M $ 34.53M PE Ratio